BENZODIOXOLE OR BENZODIOXEPINE HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS
    101.
    发明申请
    BENZODIOXOLE OR BENZODIOXEPINE HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS 有权
    作为磷酸二酯酶抑制剂的苯二酚或苯并二氧杂环己烷化合物

    公开(公告)号:US20130123291A1

    公开(公告)日:2013-05-16

    申请号:US13806659

    申请日:2011-06-24

    Abstract: Compounds of the general formula (I) wherein each of m and n is independently 0 or 1; R1 and R2, together with the carbon atom to which they are attached, form a heterocyclic ring comprising one or two heteroatoms selected from oxygen, sulfur, —S(O)— and —S(0)2-; R3 is —CHF2, —CF3, —OCHF2, —OCF3, —SCHF2 or —SCF3; X is a bond, —CH2—, or —NH—; A is aryl, cycloalkyl, cycloalkenyl, arylalkyl, heteroaryl, heteroarylalkyl, heterocycloalkyl or heterocycloalkenyl, optionally substituted with one or more, same or different substituents selected from R4; and R4 is hydrogen, amino, thioxo, alkyl, haloalkyl, hydroxyalkyl, alkoxy, haloalkoxy, halogen, oxo, thia, or hydroxy; or pharmaceutically acceptable salts, hydrates or solvates thereof, have been found to exhibit PDE4 inhibiting activity, and may therefore be useful in the treatment of inflammatory diseases and disorders.

    Abstract translation: 通式(I)的化合物,其中m和n各自独立地为0或1; R1和R2与它们所连接的碳原子一起形成包含一个或两个选自氧,硫,-S(O) - 和-S(O)2 - 的杂原子的杂环; R3是-CHF2,-CF3,-OCHF2,-OCF3,-SCHF2或-SCF3; X是键,-CH 2 - 或-NH-; A是任选被一个或多个相同或不同的选自R4的取代基取代的芳基,环烷基,环烯基,芳基烷基,杂芳基,杂芳基烷基,杂环烷基或杂环烯基。 R 4是氢,氨基,硫代,烷基,卤代烷基,羟基烷基,烷氧基,卤代烷氧基,卤素,氧代,硫杂或羟基; 已发现其药学上可接受的盐,水合物或溶剂化物表现出PDE4抑制活性,因此可用于治疗炎性疾病和病症。

    Cyanoguanidine prodrugs
    108.
    发明申请
    Cyanoguanidine prodrugs 审中-公开
    氰基胍前药

    公开(公告)号:US20060014804A1

    公开(公告)日:2006-01-19

    申请号:US10514498

    申请日:2003-05-15

    Applicant: Ernst Binderup

    Inventor: Ernst Binderup

    CPC classification number: C07D213/75

    Abstract: Pyridyl cyanoguanidine compounds according to formula I wherein A, R1, R2, R5, R6, X1, X2, X3, X4, Y1, Y2, Y3, Y4 and n are as indicated in the description are useful as prodrugs in human veterinary therapy of proliferative diseases such as cancers.

    Abstract translation: 式I的吡啶基氰基胍化合物,其中A 1,R 2,R 2,R 5,R 6, X 1,X 2,X 3,X 4,Y 1,X 1,X 2, Y 2 Y 3,Y 3,Y 4和n如说明书中所示,可用作人类兽医治疗增殖性疾病中的前药,例如 癌症

Patent Agency Ranking